Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Non-Current Debt (2018 - 2026)

Select Medical Holdings (SEM) has disclosed Non-Current Debt for 9 consecutive years, with $1.8 billion as the latest value for Q1 2026.

  • For Q1 2026, Non-Current Debt rose 3.85% year-over-year to $1.8 billion; the TTM value through Mar 2026 reached $1.8 billion, up 3.85%, while the annual FY2025 figure was $1.8 billion, 6.65% up from the prior year.
  • Non-Current Debt hit $1.8 billion in Q1 2026 for Select Medical Holdings, up from $1.8 billion in the prior quarter.
  • Across five years, Non-Current Debt topped out at $3.8 billion in Q4 2022 and bottomed at $1.7 billion in Q4 2024.
  • Average Non-Current Debt over 5 years is $3.0 billion, with a median of $3.6 billion recorded in 2024.
  • Year-over-year, Non-Current Debt rose 10.82% in 2022 and then tumbled 52.98% in 2025.
  • Select Medical Holdings' Non-Current Debt stood at $3.8 billion in 2022, then decreased by 6.54% to $3.6 billion in 2023, then plummeted by 52.81% to $1.7 billion in 2024, then grew by 6.65% to $1.8 billion in 2025, then increased by 1.75% to $1.8 billion in 2026.
  • According to Business Quant data, Non-Current Debt over the past three periods came in at $1.8 billion, $1.8 billion, and $1.7 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.